Pharma giant Eli Lilly said it is negotiating to raise drug prices in Europe, starting in the U.K. with the weight-loss drug Mounjaro, so that it can comply with the Trump administration’s goal of ...

Explore Eli Lilly’s role in Healthcare Stocks, S&P 500 companies, and its impact on market trends and the S&P 500 index.

By Sneha S K (Reuters) -Telehealth company HealthTap said on Wednesday it is joining Eli Lilly's digital healthcare platform, ...

Eli Lilly shares are trading higher Wednesday after Trump recently announced a deal with Pfizer as well as the 'TrumpRx' site to decrease prices.

A sign for Eli Lilly and Company sits outside its corporate headquarters in Indianapolis on April 26, 2017. Pharmaceutical corporation Eli Lilly and Company plans to build a $6.5 billion manufacturing ...

Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind ...

Eli Lilly’s new GLP-1 drug and diversified R&D pipeline could drive healthcare sector inflows and deliver over 40% upside.

Eli Lilly CEO Dave Ricks criticizes UK drug pricing and rebate rules as pharma giants scale back investments, warning of fewer new medicines.

Eli Lilly and Co.’s experimental obesity pill helped patients lose 9.6% of their body weight in a trial that moves the company one step closer to a potential approval. The company’s shares rose as ...

It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting impressive results following a large, robust 72-week trial that saw obese ...

Patient groups urge U.K.’s antitrust regulator to investigate drugmakers for “suspected” and “coordinated” efforts to drive ...

Five Connersville High School seniors have been selected by the Fayette Community Foundation as finalists for the 2026 Lilly ...